The Digital Family Office for Biology

What Nuletic is

Nuletic is a physician-supervised biological optimization platform that combines hormone therapy, GLP-1 weight management, peptide therapy, cognitive health protocols, and longevity interventions under one clinical roof. The platform serves men, women, couples, and organizations.

Nuletic will integrate physician-supervised treatment protocols with AI-powered optimization and continuous biomarker monitoring. Every patient will receive a dedicated physician who targets individual optimal levels, not population-average reference ranges.

The platform is launching telehealth services in 2026. Phase 1 (current) is the most comprehensive evidence-based health education library in the optimization space, with 90+ guides, 24 peptide encyclopedia entries, and 250+ cited research references.

Why Nuletic exists

Standard medicine is built for disease treatment, not optimization. A testosterone level of 300 ng/dL is technically “normal,” but the patient may be exhausted, foggy, and declining. A woman in perimenopause is told her symptoms are “just stress” when they are hormonal signals that can be addressed.

Reference ranges are population averages designed for epidemiology, not individual care. Millions of adults fall within “normal” ranges while experiencing significant symptoms that affect their work, relationships, and quality of life.

Nuletic exists to close that gap. The platform provides the kind of individualized, data-driven optimization that was previously available only through ultra-premium concierge medicine ($50K-$150K/year) at a price point accessible to the mass-affluent market.

How Nuletic is different

Three principles define the Nuletic approach:

• “Normal” is not optimal.Standard medical reference ranges are designed for population averages, not individual optimization. Nuletic targets each patient's optimal based on symptoms, biomarkers, genetics, and goals.
• Compliance is the brand. In an industry of grey-market operators and clinics under FTC/FDA scrutiny, Nuletic chose the hard path: pharmaceutical-grade compounds from FDA-registered 503B pharmacies, physician-supervised protocols, and batch-specific certificates of analysis. Compliance is not a cost center. It is the competitive moat.
• Your biology is beautiful. Health data should inspire, not overwhelm. The Bio-Aesthetics Engine transforms biomarker data into living generative art. As health improves, the art evolves.

What Nuletic is building

The platform has three pillars:

• Nuletic Prime — Physician-supervised hormone therapy, GLP-1 weight management, peptide therapy, and longevity protocols. Each patient will receive a dedicated physician who manages their complete protocol.
• Nuletic OS — AI-powered protocol optimization that integrates bloodwork, wearable data (WHOOP, Oura, CGM), and medication response to recommend adjustments proactively.
• Nuletic Legacy — The Bio-Aesthetics Engine that transforms health data into living generative art. A visual representation of biological optimization over time.

Clinical standards being established

• Building on an MSO (Management Services Organization) legal structure to separate business operations from clinical decision-making
• All compounds will be sourced from FDA-registered 503A/503B compounding pharmacies or standard pharmacies
• Every protocol will be supervised by a licensed, board-certified physician
• Evidence-based content with 250+ citations from peer-reviewed research and medical society guidelines
• Zero grey-market sourcing. Zero “research chemical” language. Zero unsupported health claims.
• Full HIPAA compliance planned for all patient data at launch

Learn about the Nuletic medical team.

Leadership

Nuletic was founded in 2026 by Val Narodetsky, a Ukrainian-born serial entrepreneur and CEO of Odesa.co. Val's experience navigating fragmented optimization care as a patient informed Nuletic's integrated platform approach. The full leadership team and medical advisory board are being assembled ahead of the 2026 telehealth launch.